Predict your next investment

Holding Company
dnscap.com

See what CB Insights has to offer

Investments

34

Portfolio Exits

5

About DNS Capital

DNS Capital is the private investment office for Gigi Pritzker Pucker, Michael Pucker and their immediate family. DNS Capital takes a long-term and flexible approach to investing, and focuses on people, relationships and culture.

DNS Capital Headquarters Location

400 N. Michigan Avenue Suite S1700

Chicago, Illinois, 60611,

United States

312-982-0027

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest DNS Capital News

Kallyope Raises $236M in Series D Financing

Feb 15, 2022

Kallyope, Inc. , a NYC-based biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, closed a $236m Series D financing. The round was co-led by Mubadala Investment Company and The Column Group, with participation from previous investors Alexandria Venture Investments, Bill Gates, Casdin Capital, Euclidean Capital, Illumina Ventures, Lux Capital, Polaris Partners, Two Sigma Ventures and StepStone Group and new investors DNS Capital, Hartford Healthcare Endowment, Parkwood LLC, and Tao Capital. The funds will be used to advance the company’s drug discovery platform, clinical trials, and pipeline of multiple programs across a broad range of therapeutic areas. Led by Jay Galeota, president and CEO, and Nancy Thornberry, founding CEO and chair, Research and Development, Kallyope provides a platform that integrates several technologies for the discovery and translation of gut-brain biology. By revealing the connections between the gut and the brain, the platform has been leveraged to generate novel programs spanning several relevant therapeutic areas, including metabolism, immunology and inflammation, and central nervous system disorders. Over the past 13 months, Kallyope has advanced four compounds into the clinic in its two lead programs in Type 2 diabetes, obesity, and diseases of the gastrointestinal barrier. The company’s founders are Charles Zuker, Ph.D., Lasker Award winner Tom Maniatis, Ph.D., and Nobel laureate Richard Axel, M.D. FinSMEs 15/02/2022

DNS Capital Investments

34 Investments

DNS Capital has made 34 investments. Their latest investment was in Kallyope as part of their Series D on February 2, 2022.

CBI Logo

DNS Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/15/2022

Series D

Kallyope

$236M

Yes

20

12/17/2021

Series B - II

Glympse Bio

$18M

No

1

7/27/2021

Series A

IMIDomics

$16.5M

Yes

11

7/19/2021

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

4/21/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/15/2022

12/17/2021

7/27/2021

7/19/2021

4/21/2021

Round

Series D

Series B - II

Series A

Series B - II

Series C

Company

Kallyope

Glympse Bio

IMIDomics

Subscribe to see more

Subscribe to see more

Amount

$236M

$18M

$16.5M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

20

1

11

10

10

DNS Capital Portfolio Exits

5 Portfolio Exits

DNS Capital has 5 portfolio exits. Their latest portfolio exit was Aspiration on August 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/18/2021

Acq - Pending

$99M

1

3/16/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/2/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/14/2017

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

7/21/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/18/2021

3/16/2021

5/2/2019

12/14/2017

7/21/2017

Exit

Acq - Pending

Acquired

IPO

Corporate Majority

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

DNS Capital Acquisitions

1 Acquisition

DNS Capital acquired 1 company. Their latest acquisition was Industrial Magnetics on February 16, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/16/2016

Debt

$99M

$16M

Acquired

1

Date

2/16/2016

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$16M

Note

Acquired

Sources

1

DNS Capital Team

3 Team Members

DNS Capital has 3 team members, including current Managing Partner, David N Siegel.

Name

Work History

Title

Status

David N Siegel

Managing Partner

Current

Scott Hairston

Managing Director

Current

Charles Tollinche

Managing Director

Current

Name

David N Siegel

Scott Hairston

Charles Tollinche

Work History

Title

Managing Partner

Managing Director

Managing Director

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.